UC proud to sponsor Kiwi Game Starter 2022 competition
The University of Canterbury (UC) continues to respond to the needs of the digital screen industries with sponsorship of the NZGDA Kiwi Game Starter 2022, a business start-up competition supporting the best of Aotearoa New Zealand’s up-and-coming game development talent.
Do you see faces in things?
Seeing faces in everyday objects is a common experience, but research from The University of Queensland has found people are more likely to see male faces when they see an image on the trunk of a tree or in burnt toast over breakfast.
RespirAq secures $1.5m investment
A company formed to commercialise innovative respiratory technology, RespirAq, developed by AUT researchers has secured $1.5m of investment from Outset Ventures, Icehouse Ventures, and Cure Kids Ventures.
Citizens recruited to unlock the secret lives of echidnas
Researchers at the University of Adelaide’s Environment Institute and members of the general public have recorded the largest number of echidna sightings across Australia to aid in the conservation of the iconic mammal.
Mothers working from home drink more in lockdown
As Kiwis stock up ahead of Omicron isolation, a researcher warns against buying extra alcohol.
Greener burials uncovered by new Canterbury research
While many are striving to live in a more eco-friendly way, a University of Canterbury (UC) academic says we should also have the option to be buried more sustainably.
Researchers discover way to disarm potentially deadly Listeria bacteria
University of Queensland researchers have unlocked a way of fighting Listeria infections, which can cause severe illness in pregnant women and people with compromised immune systems.
Nanobubbles a pathway to better medical devices
Tiny gas bubbles could help reduce drag in small medical devices, university scientists have found. Drag can lead to clogging and damage biological samples, so this discovery could pave the way to more robust devices.
The low-cost widely available drug that could fight COVID-19
A widely available and affordable drug, heparin, limits lung damage when inhaled by COVID-19 patients, according to world-first findings by researchers from The Australian National University (ANU).
Interdisciplinary team wins health grant
Researchers from across AUT have received a $1,364,660 grant from the Health Research Council (HRC) to collaborate with Ngā Maia Māori Midwives Aotearoa, Pasifika Midwives Aotearoa...

















































